Akebia
Therapeutics, Inc. is a biopharmaceutical company, which engages in the
development and commercialization of therapeutics for patients with
kidney diseases. The firm is also involved in the development and
commercialization of drugs for the treatment of renal and metabolic
disorders. Its products include Auryxia and Vadadustat. The company was
founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P.
Fairbank, and Robert A. Shalwitz on February 27, 2007 and is
headquartered in Cambridge, MA. The listed name for AKBA is Akebia
Therapeutics, Inc. Common Stock.
No comments:
Post a Comment